Vanguard Group Inc Enveric Biosciences, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$4.22 - $13.1 $3.21 Million - $9.96 Million
-760,589 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$46.5 - $104.0 $12.3 Million - $27.6 Million
264,936 Added 53.45%
760,589 $707,000
Q3 2021

Nov 12, 2021
BUY
$80.5 - $175.0 $25.3 Million - $55 Million
314,070 Added 172.96%
495,653 $1.03 Million
Q2 2021

Aug 13, 2021
BUY
$95.0 - $156.5 $17.3 Million - $28.4 Million
181,583 New
181,583 $432,000

About Enveric Biosciences, Inc.

ENVB Quotes by TradingView
  • Ticker ENVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,078,270
  • Market Cap $686K
  • Description
  • Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...
More about ENVB
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email